jRCT2051230090
Untitled Trial
Phase 2 randomized double blind controlled study to investigate disease modifying effect, safety and optimal dose of oral semaglutide tablet for patients with Parkinson's disease (MOST ABLE study)
Japan Registry Clinical TrialNot yet recruiting
Study focus
- Disease/Condition
- Parkinson's disease
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCT2051230090
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCT2051230090 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Not yet recruiting. The study focuses on Parkinson's disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.